Your browser doesn't support javascript.
loading
Phase II study of imatinib-based chemotherapy for newly diagnosed BCR-ABL-positive acute lymphoblastic leukemia.
Fujisawa, Shin; Mizuta, Shuichi; Akiyama, Hideki; Ueda, Yasunori; Aoyama, Yasutaka; Hatta, Yoshihiro; Kakihana, Kazuhiko; Dobashi, Nobuaki; Sugiura, Isamu; Onishi, Yasushi; Maeda, Tomoya; Imai, Kiyotoshi; Ohtake, Shigeki; Miyazaki, Yasushi; Ohnishi, Kazunori; Matsuo, Keitaro; Naoe, Tomoki.
Afiliação
  • Fujisawa S; Department of Hematology, Yokohama City University Medical Center, Yokohama, Japan.
  • Mizuta S; Department of Hematology, Fujita Health University Hospital, Toyoake, Japan.
  • Akiyama H; Tokyo Metropolitan Health and Medical Treatment Corporation Tama-Hokubu Medical Center, Tokyo, Japan.
  • Ueda Y; Department of Hematology/Oncology, Kurashiki Central Hospital, Kurashiki, Japan.
  • Aoyama Y; Department of Hematology, Seichokai Fuchu Hospital, Osaka, Japan.
  • Hatta Y; Department of Hematology and Rheumatology, Nihon University School of Medicine, Tokyo, Japan.
  • Kakihana K; Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan.
  • Dobashi N; Division of Clinical Oncology and Hematology, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan.
  • Sugiura I; Division of Hematology and Oncology, Toyohashi Municipal Hospital, Toyohashi, Japan.
  • Onishi Y; Department of Hematology and Rheumatology, Tohoku University Hospital, Sendai, Japan.
  • Maeda T; Department of Hemato-Oncology, Saitama Medical University International Medical Center, Hidaka, Japan.
  • Imai K; Department of Hematology, Sapporo Hokuyu Hospital, Sapporo, Japan.
  • Ohtake S; Institute of Liberal Arts and Science, Kanazawa University, Kanazawa, Japan.
  • Miyazaki Y; Department of Hematology, Atomic Bomb Disease Institute, Nagasaki University, Nagasaki, Japan.
  • Ohnishi K; Oncology Center, Hamamatsu University School of Medicine, Hamamatsu, Japan.
  • Matsuo K; Division of Molecular Medicine, Aichi Cancer Center Research Institute, Nagoya, Japan.
  • Naoe T; National Hospital Organization Nagoya Medical Center, Nagoya, Japan.
Am J Hematol ; 92(4): 367-374, 2017 Apr.
Article em En | MEDLINE | ID: mdl-28103625
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia-Linfoma Linfoblástico de Células Precursoras / Mesilato de Imatinib Tipo de estudo: Diagnostic_studies Limite: Adolescent / Adult / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia-Linfoma Linfoblástico de Células Precursoras / Mesilato de Imatinib Tipo de estudo: Diagnostic_studies Limite: Adolescent / Adult / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2017 Tipo de documento: Article